Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Junichi Fukada"'
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Cabazitaxel (CBZ) is approved for the treatment of docetaxel-resistant castration-resistant prostate cancer (CRPC). However, its efficacy against CRPC is limited, and there are no effective treatments for CBZ-resistant CRPC. This study explo
Externí odkaz:
https://doaj.org/article/56f8f480566741bda2848c462abb3516
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract We investigated the normal tissue complication probability (NTCP) of the incidence of pericardial effusion (PCE) based on the mean heart dose (MHD) in patients with oesophageal cancer treated with definitive chemoradiotherapy. The incidences
Externí odkaz:
https://doaj.org/article/f5b7191eac134185ba4539b22de58951
Autor:
Yutaka Endo, Minoru Kitago, Koichi Aiura, Masahiro Shinoda, Hiroshi Yagi, Yuta Abe, Go Oshima, Shutaro Hori, Yutaka Nakano, Osamu Itano, Junichi Fukada, Yohei Masugi, Yuko Kitagawa
Publikováno v:
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-8 (2019)
Abstract Background We aimed to evaluate the efficacy and safety of 5-fluorouracil-based neoadjuvant chemoradiotherapy (NACRT) in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC). Methods This retrospective study
Externí odkaz:
https://doaj.org/article/f17e6ef287d24d8ead3b7a5cc4345689
Autor:
Masahiro Yura, Tsunehiro Takahashi, Kazumasa Fukuda, Rieko Nakamura, Norihito Wada, Junichi Fukada, Hirofumi Kawakubo, Hiroya Takeuchi, Naoyuki Shigematsu, Yuko Kitagawa
Publikováno v:
Case Reports in Gastroenterology, Vol 12, Iss 3, Pp 578-585 (2018)
We report a patient with highly advanced gastric carcinoma who was treated successfully with chemoradiotherapy (CRT) comprising S-1 and cisplatin. The patient was a 71-year-old male who was diagnosed with advanced gastric carcinoma by esophagogastrod
Externí odkaz:
https://doaj.org/article/e9766784040149178b2d50bf0fe8e51b
Autor:
Yoshiki Owaki, Tadaki Nakahara, Takeo Kosaka, Junichi Fukada, Atsuhiro Kumabe, Akira Ichimura, Mikoto Murakami, Kiyotaka Nakajima, Masahiro Fukushi, Kazumasa Inoue, Mototsugu Oya, Masahiro Jinzaki
Publikováno v:
EJNMMI Research, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Background Image-based measurement of absorbed dose of Ra-223 dichloride may be useful in predicting therapeutic outcome in patients with castration-resistant prostate cancer (CRPC). In general, SPECT has been found to be more accurate than
Externí odkaz:
https://doaj.org/article/aeee270523b440eba95076a530ec1c5d
Publikováno v:
Keio Journal of Medicine; 2024, Vol. 73 Issue 2, p15-23, 9p
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
We investigated the normal tissue complication probability (NTCP) of the incidence of pericardial effusion (PCE) based on the mean heart dose (MHD) in patients with oesophageal cancer treated with definitive chemoradiotherapy. The incidences of PCE i
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Cabazitaxel (CBZ) is approved for the treatment of docetaxel-resistant castration-resistant prostate cancer (CRPC). However, its efficacy against CRPC is limited, and there are no effective treatments for CBZ-resistant CRPC. This study explored the o
We investigated the normal tissue complication probability (NTCP) of the incidence of pericardial effusion (PCE) based on the mean heart dose (MHD). We reviewed medical records of oesophageal cancer patients treated with definitive chemoradiotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c44387b0570004f7817e05a05e29b84
https://doi.org/10.21203/rs.3.rs-421111/v1
https://doi.org/10.21203/rs.3.rs-421111/v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.